Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy
Not available.
Saved in:
| Main Authors: | Sarah Cadot, Loïc Ysebaert, Sébastien Lamy, Camille Laurent, Anne Quillet-Mary |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2024-09-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11765 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD4+/CD8- T cell large granular lymphocytic leukemia: A rare entity
by: Ashish Gupta, et al.
Published: (2019-01-01) -
Expansion of CD103+CD69+CD8+ cytotoxic liver tissue resident memory T cells and inflammatory monocytes in advanced biliary atresia
by: Freya Sibbertsen, et al.
Published: (2025-06-01) -
INTERACTION OF T-LYMPHOCYTES OF CD4+CD27HI AND CD4+CD27LO WITH MACROPHAGES IN TUBERCULOUS INFECTION IN MICE
by: G. S. Syepel'kova, et al.
Published: (2015-12-01) -
HSP and CD279 gene expression as candidate biomarkers in symptomatic LGLL patients
by: Giovanna Talarico, et al.
Published: (2024-12-01) -
CD69+CD103+CD8+ tissue-resident memory T cells possess stronger anti-tumor activity and predict better prognosis in colorectal cancer
by: Zi-Xin Wu, et al.
Published: (2024-12-01)